ClinConnect ClinConnect Logo
Search / Trial NCT01255605

Impact of IPT With Sulfadoxin Pyrimetamin on Pregnant Women and Their Babies Outcomes in Peri-urban Areas of Bobo-Dioulasso(Burkina Faso)

Launched by UNIVERSITÉ POLYTECHNIQUE DE BOBO-DIOULASSO · Dec 6, 2010

Trial Information

Current as of May 11, 2025

Completed

Keywords

Intermittent Preventive Treatment With Sulfadoxin Pyrimethamine In Bobo Dioulasso Peri Urban Areas, 5 Years After Its Implementation Burkina Faso.

ClinConnect Summary

Malaria in pregnant women is a crucial issue in Burkina Faso. Faced with this problem, a strategy based on the use of treated nets and intermittent preventive treatment (IPT) based on sulfadoxine-pyrimethamine (SP) was adopted in 2005. Five years after its implementation, the investigators will check whether this strategy is still effective in the preventing maternal and congenital malaria on the one hand and maternal anemia, low birth weight and prematurity on the other hand.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Residing in the health area of Lafiabougou or secteur 24
  • Having agreed to give free and informed consent
  • Exclusion Criteria:
  • Bleeding from during the pregnancy
  • eclampsia

About Université Polytechnique De Bobo Dioulasso

Université Polytechnique de Bobo-Dioulasso is a leading academic institution located in Burkina Faso, dedicated to advancing research and innovation in various fields, including health sciences. The university plays a pivotal role in fostering collaboration between researchers, healthcare professionals, and industry stakeholders to address pressing health challenges through rigorous clinical trials. Committed to ethical standards and scientific excellence, the university aims to contribute significantly to the understanding and improvement of health outcomes in the region and beyond. Its multidisciplinary approach ensures comprehensive evaluation and implementation of clinical research initiatives, ultimately enhancing the quality of care and health services.

Locations

Bobo Dioulasso, Houet, Burkina Faso

Patients applied

0 patients applied

Trial Officials

Mamoudou Cisse, MD

Principal Investigator

Centre MURAZ Research Institute

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials